FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22486711000001109: Roletra 10mg tablets (Ranbaxy (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Jun 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
74111401000001111 Roletra 10mg tablets (Ranbaxy (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
74111501000001110 Roletra 10mg tablets (Ranbaxy (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Is a Product containing precisely loratadine 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has active ingredient Loratadine false Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has specific active ingredient Loratadine true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Is a Roletra true Inferred relationship Existential restriction modifier
Roletra 10mg tablets (Ranbaxy (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Roletra 10mg tablets (Ranbaxy (UK) Ltd) 7 tablet Has AMP True Roletra 10mg tablets (Ranbaxy (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start